Cellebrite DI (CLBT) Cash & Current Investments (2020 - 2025)

Cellebrite DI's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $285.5 million for Q4 2025.

• In Q4 2025, Cash & Current Investments fell 17.34% year-over-year to $285.5 million; the TTM figure through Dec 2025 stood at $285.5 million (down 17.34% YoY), while the FY2025 annual figure was $285.5 million, down 16.83% from the prior year.
• Cash & Current Investments was $285.5 million for Q4 2025 at Cellebrite DI, up from $191.7 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $345.4 million in Q4 2024 to a low of $84.6 million in Q3 2022.
• Historically, Cash & Current Investments has averaged $157.5 million across 5 years, with a median of $142.8 million in 2021.
• The sharpest annual moves came in 2022 and 2025: Cash & Current Investments sank 46.14% in 2022, then surged 79.19% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $146.0 million in 2021, then dropped by 9.38% to $132.3 million in 2022, then jumped by 72.51% to $228.2 million in 2023, then jumped by 51.35% to $345.4 million in 2024, then fell by 17.34% to $285.5 million in 2025.
• The last three Cash & Current Investments figures came in at $285.5 million (Q4 2025), $191.7 million (Q3 2025), and $191.7 million (Q2 2025), per Business Quant data.